Understanding cognitive decline in older adults with depression
Official title: Characterizing Cognitive Decline in Late Life Depression: The Alzheimer's Disease Neuroimaging Initiative - Depression Project
Run by University of Southern California · NCT02434393 · Data updated 2026-11-12
This study is trying to understand how depression affects thinking and memory in older adults by looking at brain scans and comparing them to people without depression.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | University of Southern California Academic / other |
| Locations | 2 sites (San Francisco, California and 1 other locations) |
| Status | Recruiting |
| Started | March 4, 2015 |
| Main results expected | May 2027 |
| Study ends | May 2027 |
| Registry record updated | November 25, 2025 |
| Trial ID | NCT02434393 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are older adults who have participated in previous related studies and are experiencing symptoms of Late Life Depression.
✕Probably not a fit
Patients who are not experiencing depression or those with unstable medication regimens may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the mechanisms behind cognitive impairment and accelerated cognitive decline in individuals suffering from Late Life Depression (LLD). It will enroll 120 participants, including those from a previous study and new participants, over a 30-month period. Participants will undergo various assessments, including MRI scans and PET imaging, to gather data on brain function and biomarkers. Additionally, data from 300 non-depressed individuals will be utilized for comparative analysis.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and management of cognitive decline in older adults with depression.
How similar studies have gone: Other studies have shown promise in understanding cognitive decline in depression, but this specific approach is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1\. Individual participated in original Characterizing Cognitive Decline in Late Life Depression study or Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression Study. Exclusion Exceptions: 1. Antidepressant medication treatment is allowed only if the medication dose is stable for 4 weeks prior to the MRI scan. 2. Psychotherapy interventions is allowed only if they have completed at least 4 weeks of individual or group psychotherapy intervention prior to the MRI scan. 3. Participants taking cognitive enhancing medications will be able to enter the study.
Where it's running
-
University of California, San Francisco
San Francisco, California, United States Recruiting -
University of Pittsburgh
Pittsburgh, Pennsylvania, United States Completed
Study contacts
- Study coordinator: Nithya Ganesh
- Email: nithya.ganesh@ucsf.edu
- Phone: (415) 300-0582
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Can tACS modulate motivation and reward signals in cannabis use disorder and depression
We’re testing whether a gentle brain stimulation method (tACS) can boost motivation and reward responses in adults with cannabis use and/or depression to see if it helps with anhedonia.
-
Neural links for real-world emotions in mood and anxiety
Researchers are testing how real-life emotional moments relate to brain activity and stress responses in young adults with mood and anxiety symptoms, using smartphones, self-reports, tasks, and MRI.
-
EEG-Guided TMS for Adults With Depression
This study tests whether delivering intermittent theta burst stimulation (iTBS) timed to brain waves using EEG can improve treatment for adults with major depressive disorder who have not responded to usual antidepressants.
-
iTBS to help anhedonia in depression (dual left DLPFC + OFC or left DLPFC alone)
A brain stimulation study tests whether intermittent theta burst stimulation can help people with major depression who have anhedonia, using both dual-target (left DLPFC and OFC) and single-target (left DLPFC) approaches.
-
One Day of Ultra-Accelerated TMS With a Dose of NRX-101 for Major Depression
This study tests whether a single day of rapid TMS plus NRX-101 can help people with moderate to severe depression see improvement over six weeks.
-
EEG microstates and inflammatory markers in treatment-resistant depression patients undergoing ECT
This study tests how electroconvulsive therapy affects brain activity patterns seen in EEG and inflammatory biomarkers in adults with treatment-resistant major depression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.